Otitis Externa Review

Pediatric Emergency Care

Volumn 20, Issue 4, 2004, Pages 250-254

  Beers, Sara L ^a   Abramo, Thomas J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

External ear infection; Otitis externa

Indexed keywords

CIPROFLOXACIN; CLOXACILLIN; HYDROCORTISONE; NEOMYCIN; OFLOXACIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT ALLERGY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; EAR PROTECTION; EXTERNAL EAR; EXTERNAL OTITIS; HUMAN; NONHUMAN; OTOTOXICITY; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; PUBLICATION; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS; SYMPTOM;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; EAR PROTECTIVE DEVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; OTITIS EXTERNA; OTOLARYNGOLOGY; PSEUDOMONAS INFECTIONS; SWIMMING;

EID: 1942454851     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000121246.99242.f5     Document Type: Review

References (20)

1. P. Martinez Devesa, et al. External auditory canal pH in chronic otitis externa. Clin Otolaryngol. 2003;28:320-324.
2. Seely DR, Quigley SM, Langman AW. Ear candles: efficacy and safety. Larygoscope. 1996;106:1226-1229.
3. Aminifarshidmehr N. The management of chronic suppurative otitis media with acid media solution. Am J Otol. 1996;17:24-25.
4. Stone M, Fulghum RS. Bactericidal activity of wet cerumen. Ann Otol Rhinol Laryngol. 1984;83:183-186.
5. Yavuz Selim Pata MD, et al. Has cerumen a protective role in recurrent otitis externa? Am J Otolaryngol. July-August 2003;24(4):209-212.
6. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope. July 2002;112:1166-1177.
7. Jones RN, Milazzo J, Seidlin M. Oflaxacin otic solution for treatment of otitis externa in children and adults. Arch Otolaryngol Head Neck Surg. 1997;123:1193-1200.
8. Pistorius B, Westberry K, Drehobl M. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of otitis externa. Infect Dis Clin Pract. 1999;8: 387-395.
9. Dickel H, et al. Delayed readings of a standard screening patch test tray: frequency of "lost," "found," and " persistent" reactions. Am J Contact Dermat. 2000;11:213-217.
10. Gates GA. Safety of oflaxacin otic and other ototopical treatments in animal models and in humans. Pediatr Infect Dis J. 2001;20:104-107.
11. Dohar JE, et al. Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes. Arch Otolaryngol Head Neck Surg. 1999; 125:537-545.
12. Scheife RT, et al. Photosensitizing potential of ofloxacin. Int J Dermatol. 1993;32:413-416.
13. Bath AP, et al. Ototoxity of topical gentamicin preparations. Laryngoscope. 1999;109:1088-1093.
14. Hughes E, Lee JH. Otitis externa. Pediatr Rev. June 2001;22(6): 191-197.
15. Klein JO, McCracken GH Jr. Summary and conclusions. Pediatr Infect Dis J. January 2001;20(1):123-125.
16. Tsikoudas Jassar P, England RJA. Are topical antibiotics necessary in the management of otitis externa? Clin Otolaryngol. March 2002; 27:260-262.
17. Tierney PA, et al. Improving standards in the treatment of acute otitis externa by the use of a treatment protocol and open access to aural toilet. J Laryngol Otol. February 2001;115:87-90.
18. Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J. April 2003;22(4):299-305.
19. Behrman MD, Kliegman MD, Jenson MD. Nelson Textbook of Pediatrics. 16th ed. 2000:1948-1949.
20. Guthrie RM, et al. Diagnosis and treatment of otitis externa. February 1999;176:1-23.